FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 251 filers reported holding FATE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $685,000 | -3.0% | 11,708 | -1.7% | 0.02% | -9.1% |
| Q3 2021 | $706,000 | -31.7% | 11,915 | 0.0% | 0.02% | -26.7% |
| Q2 2021 | $1,034,000 | +123.3% | 11,915 | +112.4% | 0.03% | +114.3% |
| Q1 2021 | $463,000 | -13.8% | 5,610 | -5.1% | 0.01% | -17.6% |
| Q4 2020 | $537,000 | -38.8% | 5,910 | -92.4% | 0.02% | -34.6% |
| Q2 2018 | $877,000 | +12.0% | 77,304 | -3.7% | 0.03% | -3.7% |
| Q1 2018 | $783,000 | – | 80,247 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |